Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 70.30
+0.23 (0.33%)
At close: Apr 21, 2026
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 9.22 billion as of April 21, 2026. Its market cap has increased by 113.29% in one year.
Market Cap
9.22B
Enterprise Value
9.01B
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
70.30
Market Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 9.22B, an increase of 109.39%. That is a compound annual growth rate of 12.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 9.25B | 24.65% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 10.67B |
| HitGen | 10.42B |
| Liaoning Chengda Biotechnology | 10.02B |
| Jiangxi Fushine Pharmaceutical | 9.83B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.64B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.40B |
| Bio-Thera Solutions | 9.37B |
| Sino Biological,Inc. | 8.96B |